BlackRock Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.03M | Buy |
45,968
+2,329
| +5% | +$52.3K | ﹤0.01% | 2102 |
|
|
2016
Q3 | $991K | Buy |
43,639
+997
| +2% | +$22.6K | ﹤0.01% | 2028 |
|
|
2016
Q2 | $1.01M | Sell |
42,642
-10,993
| -20% | -$260K | ﹤0.01% | 1960 |
|
|
2016
Q1 | $1.1M | Buy |
53,635
+26,488
| +98% | +$541K | ﹤0.01% | 1886 |
|
|
2015
Q4 | $1.4M | Buy |
27,147
+6,184
| +29% | +$318K | ﹤0.01% | 1676 |
|
|
2015
Q3 | $894K | Buy |
20,963
+10,416
| +99% | +$444K | ﹤0.01% | 1935 |
|
|
2015
Q2 | $481K | Buy |
10,547
+1,596
| +18% | +$72.8K | ﹤0.01% | 2271 |
|
|
2015
Q1 | $340K | Buy |
8,951
+4,497
| +101% | +$171K | ﹤0.01% | 2314 |
|
|
2014
Q4 | $126K | Buy |
+4,454
| New | +$126K | ﹤0.01% | 2616 |
|
|
2013
Q4 | – | Sell |
-3,280
| Closed | -$88K | – | 2799 |
|
|
2013
Q3 | $88K | Buy |
+3,280
| New | +$88K | ﹤0.01% | 2613 |
|